Aisen PS, et al. “Clinical Core of the Alzheimer’s Disease Neuroimaging Initiative: Progress and Plans,” Alzheimer’s & Dementia (May 2010): Vol. 6, No. 3, pp. 239–46. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20451872

Alzheimer’s Association. Proposed Revisions to Diagnostic Criteria for Alzheimer’s Disease: Backgrounder/FAQ, available online at www.alz.org/research/diagnostic_criteria.

“Consensus Report of the Working Group on ‘Molecular and Biochemical Markers of Alzheimer’s Disease,’ The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group,” Neurobiology of Aging (March-Apr. 1998): Vol. 19, No. 2, pp. 109–16. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9558143

Craig-Schapiro R, et al. “Biomarkers of Alzheimer’s Disease,” Neurobiology of Disease (Aug. 2009): Vol. 35, No. 2, pp. 128–40. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19010417

De Meyer G, et al. “Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People,” Archives of Neurology (Aug. 2010): Vol. 67, No. 8, pp. 949–56. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20697045

Engelborghs S, et al. “Diagnostic Performance of a CSF-Biomarker Panel in Autopsy-Confirmed Dementia,” Neurobiology of Aging (Aug. 2008): Vol. 29, No. 8, pp. 1143–59. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17428581

Gever J. “Amyloid Theory in Alzheimer’s Takes Another Hit,” MedPage Today, Aug. 17, 2010.

Hansson O, et al. “Association Between CSF Biomarkers and Incipient Alzheimer’s Disease in Patients with Mild Cognitive Impairment: A Follow-Up Study,” Lancet Neurology (March 2006): Vol. 5, No. 3, pp. 228–34. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16488378

Herskovits AZ, et al. “Sharpen that Needle,” Archives of Neurology (Aug. 2010): Vol. 67, No. 8, pp. 918–20. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20697041

Mattsson N, et al. “CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment,” Journal of the American Medical Association (July 22, 2009): Vol. 302, No. 4, pp. 385–93. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19622817

Petersen RC, et al. “Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical Characterization,” Neurology (Jan. 19, 2010): Vol. 74, No. 3, pp. 201–09. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20042704

Petersen RC, et al. “Use of Alzheimer Disease Biomarkers: Potentially Yes for Clinical Trials but Not Yet for Clinical Practice,” Journal of the American Medical Association (July 22, 2009): Vol. 302, No. 4, pp. 436–37. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19622825

Rosenberg PB, et al. “A Clinical Approach to Mild Cognitive Impairment,” American Journal of Psychiatry (Nov. 2006): Vol. 163, No. 11, pp. 1884–90. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17074938

Wolk DA, et al. “Update on Amyloid Imaging: From Healthy Aging to Alzheimer’s Disease,” Current Neurology and Neuroscience Reports (Sept. 2009): Vol. 9, No. 5, pp. 345–52. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19664363